
Mahima Datla
About Mahima Datla
Mahima Datla is the managing director of Biological E, a privately held vaccine producer, in which she holds a controlling stake.
The Hyderabad-based company's portfolio includes Corbevax, a Covid-19 vaccine developed in partnership with Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston.
Biological E has 10 vaccines pre-qualified by the World Health Organization including those against polio, tetanus and measles. It exports vaccines to more than 130 countries.
Biological E was founded in 1953 by her paternal and maternal grandfathers.
In July 2025 Bioligcal E struck a licensing agreement with China's Jiangsu Recbio Technology to manufacture and commercialize HPV vaccines to combat cancer.
Personal stats
Citizenship
IndiaSource of wealth
VaccinesResidence
Hyderabad, IndiaMarital status
SingleBirth date
07/16/77 (age 49)Education
Bachelor of Business Administration, Webster UniversitySelf-made
inherited and growingMahima Datla’s fortune is worth

troy ounces of gold

median U.S. household

median U.S. income

U.S. credit card volume

GDP of the United States

United States debt
Net worth history
Annual ranking
Did you know?
Datla has a bachelor's degree in business management from London's Webster University. She became managing director in 2013.
Net worth over time
Real-time ranking
Images © Forbes.com. All rights reserved.
